• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

The psychology behind why people will take horse paste, but not COVID vaccines

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
September 2, 2021, 5:30 PM ET

Say you’re in the midst of an unprecedented global pandemic. To protect yourself, you have a choice between vaccines that were tested on tens of thousands of people in rigorous clinical trials specifically for the purpose of combating COVID-19, or a decades-old drug like ivermectin that is most commonly known as a powerful parasite fighting treatment, often used for horses and livestock.

One option has been endorsed by scientists, regulators, academic institutions, public health experts, and government leaders alike and proved remarkably effective as vaccines have been doled out to billions of people across the world less than a year into the outbreak; the other has a handful of approved uses in humans but no robust clinical evidence that it works against coronavirus illness, a fact the aforementioned experts repeatedly raise while warning against its off-label use for COVID. Which one of these would you take? And, more importantly if you’re going the equine dewormer route, why?

It’s a head-scratcher as a small but growing number of Americans—many of them from the anti-vaxxer or vaccine skeptic crowd—have pushed demand for ivermectin prescriptions (and the version for animals) into high gear over the past few months. This medical counterculture harbors an abiding belief that the efficacy and safety of COVID vaccines is overblown as well as a mistrust of pharmaceutical companies, government officials, and media narratives around the pandemic. The politicization of COVID public health efforts certainly doesn’t help matters since ideology is one of the strongest indicators of whether or not someone is a COVID vaccine skeptic. There were usually about 3,600 ivermectin prescriptions issued weekly in the U.S. prior to the pandemic; by mid-August, that number had jumped to 88,000 per week.

This is despite the fact that the Food and Drug Administration (FDA), the World Health Organization (WHO), and the very maker of ivermectin itself, pharma giant Merck, have all urged people not to go out and take large amounts of a livestock-focused drug to stop the coronavirus given the sheer lack of evidence it works and the very real risks of overdoses and hospitalization (the WHO recommends against any type of COVID-related ivermectin use outside of a clinical trial). The FDA is a bit more blunt and points out that ivermectin isn’t even meant to fight viruses.

“FDA has not approved ivermectin for use in treating or preventing COVID-19 in humans. Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an anti-viral (a drug for treating viruses),” the agency says, noting reports of more people landing in the hospital from ivermectin overdoses. (It turns out your typical human shouldn’t take similar doses of a treatment as what’s given to a 1,000 pound horse.)

Mistrust in institutions and mainstream narratives is nothing new among certain slices of the populace. But why pair that mistrust with advocating for a completely different drug? Scottish psychologist and public health communicator Stuart Ritchie, a lecturer at King’s College London, has a fairly simple assessment of what’s driving the current ivermectin frenzy, much like the clamoring over hydroxychloroquine, an unproven treatment for COVID touted by former President Donald Trump.

“The reason for the double-standard is obvious: contrarianism. Treatments such as ivermectin (and hydroxychloroquine and Vitamin D) have never had mainstream approval, or the nod from U.K. or U.S. medical regulators for their use against COVID,” he wrote in a recent column for the NewStatesman. “The contrarians can get excited about the apparently dramatic effects of ivermectin without having to agree with people they regard as wildly wrong on case rates, death rates, the effects of lockdowns, and so on. They also get to feel the frisson of telling the world that they know better: they have secret knowledge about a super-important treatment, and the blinkered medical community just won’t listen.”

Numerous studies delving into the psychology of vaccine skeptics pick up on this contrarian bent, including significant evidence that presenting facts and data to anti-vaxxers typically makes them double down on their scientifically invalidated positions. It turns out that same quirk of psychology can also lead some people to champion an obscure animal drug in an act of epistemological defiance, especially when they can point to validation from politically charged organizations like America’s Frontline Doctors and the social media feeds of like-minded people.

The ivermectin-for-coronavirus crowd is still a pretty small slice of the population. But it’s a vocal one with the ability to reach millions of people via social media and drive unnecessary hospitalizations from overdoses in a moment when ICUs are already at the breaking point from treating COVID patients.

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Healthsleep
8 Best Firm Mattresses in 2026: Tested and Reviewed by Sleep Experts
By Christina SnyderFebruary 27, 2026
4 hours ago
HealthFood and drink
Chains like Sweetgreen and Chipotle are finally realizing they need to look beyond the ‘slop bowl’
By Phil WahbaFebruary 27, 2026
7 hours ago
chat
Healthchat
Here are the 7 rules of group chats, including how to leave when you’ve had enough
By Kelvin Chan and The Associated PressFebruary 27, 2026
10 hours ago
will
CommentaryAdvertising
I’m one of America’s top pollsters and I’ve got a warning for the AI companies: customers aren’t sold on ads
By Will JohnsonFebruary 27, 2026
16 hours ago
Healthsleep
5 Best Latex Mattresses in 2026: Tested and Reviewed by Sleep Experts
By Christina SnyderFebruary 26, 2026
1 day ago
dolly
Lawphilanthropy
Dolly Parton’s Tennessee philanthropy kicks up a notch with renaming of East Tennessee Children’s Hospital
By James Pollard and The Associated PressFebruary 26, 2026
1 day ago

Most Popular

placeholder alt text
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’
By Marco Quiroz-GutierrezFebruary 25, 2026
2 days ago
placeholder alt text
Success
Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that first step’
By Sydney LakeFebruary 25, 2026
2 days ago
placeholder alt text
Economy
Trump claims America is ‘winning so much.’ The IMF agrees, adding that Trump’s trade policies are the only thing holding it back from even more
By Tristan BoveFebruary 26, 2026
1 day ago
placeholder alt text
Commentary
'The Pitt': a masterclass display of DEI in action 
By Robert RabenFebruary 26, 2026
1 day ago
placeholder alt text
Economy
It’s more than George Clooney moving to France: America is becoming the ‘uncool’ country that people want to move away from
By Nick LichtenbergFebruary 27, 2026
17 hours ago
placeholder alt text
Success
Gen Z Olympic champion Eileen Gu says she rewires her brain daily to be more successful—and multimillionaire founder Arianna Huffington says it really does work
By Orianna Rosa RoyleFebruary 25, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.